A detailed history of Baker Tilly Wealth Management, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Baker Tilly Wealth Management, LLC holds 5,484 shares of EXAS stock, worth $315,604. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,484
Previous 5,471 0.24%
Holding current value
$315,604
Previous $231,000 61.47%
% of portfolio
0.17%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$42.43 - $70.83 $551 - $920
13 Added 0.24%
5,484 $373,000
Q2 2024

Jul 18, 2024

SELL
$41.33 - $74.26 $5,662 - $10,173
-137 Reduced 2.44%
5,471 $231,000
Q1 2024

May 09, 2024

BUY
$56.27 - $73.77 $731 - $959
13 Added 0.23%
5,608 $387,000
Q4 2023

Jan 10, 2024

SELL
$59.06 - $75.72 $21,852 - $28,016
-370 Reduced 6.2%
5,595 $413,000
Q3 2023

Oct 10, 2023

BUY
$65.94 - $99.04 $393,332 - $590,773
5,965 New
5,965 $406,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Baker Tilly Wealth Management, LLC Portfolio

Follow Baker Tilly Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.